{"transactions":[{"id":714956,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-07T00:25:29.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":124414,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.99,"exercise_date":"2024-06-10","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":124414},"source":{"system":"sec-edgar","filing":"0001849739-26-000014","document":"wk-form4_1783383927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000014/wk-form4_1783383927.xml","form_type":"4"}},{"id":714955,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-07T00:25:29.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":35064,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.98,"exercise_date":"2023-06-12","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":35064},"source":{"system":"sec-edgar","filing":"0001849739-26-000014","document":"wk-form4_1783383927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000014/wk-form4_1783383927.xml","form_type":"4"}},{"id":714954,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T00:25:29.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":159478,"price":9.0236,"value":1439065.6808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 159,478 shares sold in the price range of $9.00 to $9.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the \"Issuer\") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001849739-26-000014","document":"wk-form4_1783383927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000014/wk-form4_1783383927.xml","form_type":"4"}},{"id":714953,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T00:25:29.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":124414,"price":2.99,"value":371997.86,"ownership":{"direct":true},"balance_after":159478,"source":{"system":"sec-edgar","filing":"0001849739-26-000014","document":"wk-form4_1783383927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000014/wk-form4_1783383927.xml","form_type":"4"}},{"id":714952,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T00:25:29.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":35064,"price":2.98,"value":104490.72,"ownership":{"direct":true},"balance_after":35064,"source":{"system":"sec-edgar","filing":"0001849739-26-000014","document":"wk-form4_1783383927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000014/wk-form4_1783383927.xml","form_type":"4"}},{"id":720975,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":124414,"derivative":{"exercise_price":2.99,"exercise_date":"2024-06-10","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720974,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35064,"derivative":{"exercise_price":2.98,"exercise_date":"2023-06-12","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720973,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":132786,"derivative":{"exercise_price":2.84,"exercise_date":"2026-06-08","expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720972,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":33549,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":124714,"derivative":{"exercise_price":2.99,"exercise_date":"2024-06-10","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":33549},"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720971,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":32173,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35764,"derivative":{"exercise_price":2.98,"exercise_date":"2023-06-12","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":32173},"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720970,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":9,"value":9000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720969,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":300,"price":2.99,"value":897.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720968,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":700,"price":2.98,"value":2086.0,"ownership":{"direct":true},"balance_after":700,"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720967,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":95722,"price":9.0075,"value":862215.915,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 95,722 shares sold in the price range of $9.00 to $9.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the \"Issuer\") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720966,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":2.84,"value":85200.0,"ownership":{"direct":true},"balance_after":95722,"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720965,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":33549,"price":2.99,"value":100311.51,"ownership":{"direct":true},"balance_after":65722,"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":720964,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:04:34.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":32173,"price":2.98,"value":95875.54,"ownership":{"direct":true},"balance_after":32173,"source":{"system":"sec-edgar","filing":"0001849739-26-000011","document":"wk-form4_1782939871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000011/wk-form4_1782939871.xml","form_type":"4"}},{"id":742966,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T00:11:10.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":65600,"derivative":{"exercise_price":7.25,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001849739-26-000007","document":"wk-form4_1781136666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000007/wk-form4_1781136666.xml","form_type":"4"}},{"id":884468,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-25T01:05:58.000Z","date":"2026-02-23","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":67937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001849739-26-000004","document":"wk-form4_1771981555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000004/wk-form4_1771981555.xml","form_type":"4"}},{"id":884467,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T01:05:58.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":10,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001849739-26-000004","document":"wk-form4_1771981555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000004/wk-form4_1771981555.xml","form_type":"4"}},{"id":884466,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T01:05:58.000Z","date":"2026-02-23","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":2.98,"value":74500.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001849739-26-000004","document":"wk-form4_1771981555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000004/wk-form4_1771981555.xml","form_type":"4"}},{"id":934119,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-22T01:33:48.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":92937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001849739-26-000002","document":"wk-form4_1769045624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000002/wk-form4_1769045624.xml","form_type":"4"}},{"id":934118,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-22T01:33:48.000Z","date":"2026-01-16","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":117937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001849739-26-000002","document":"wk-form4_1769045624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000002/wk-form4_1769045624.xml","form_type":"4"}},{"id":934117,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T01:33:48.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":7.506,"value":187650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $7.50 to $7.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001849739-26-000002","document":"wk-form4_1769045624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000002/wk-form4_1769045624.xml","form_type":"4"}},{"id":934116,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T01:33:48.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":2.98,"value":74500.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001849739-26-000002","document":"wk-form4_1769045624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000002/wk-form4_1769045624.xml","form_type":"4"}},{"id":934115,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T01:33:48.000Z","date":"2026-01-16","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":5,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001849739-26-000002","document":"wk-form4_1769045624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000002/wk-form4_1769045624.xml","form_type":"4"}},{"id":934114,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T01:33:48.000Z","date":"2026-01-16","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":2.98,"value":149000.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001849739-26-000002","document":"wk-form4_1769045624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000184973926000002/wk-form4_1769045624.xml","form_type":"4"}},{"id":1104895,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T22:34:57.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":162786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 18, 2026 or the date immediately preceding the Issuer's next annual meeting of stockholders."}],"balance_after":162786,"derivative":{"exercise_price":2.84,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":162786},"source":{"system":"sec-edgar","filing":"0001326110-25-000094","document":"wk-form4_1750458891.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000094/wk-form4_1750458891.xml","form_type":"4"}},{"id":1480430,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T22:49:28.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":77633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 11, 2025 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":77633,"derivative":{"exercise_price":5.96,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":77633},"source":{"system":"sec-edgar","filing":"0001326110-24-000078","document":"wk-form4_1718318961.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000078/wk-form4_1718318961.xml","form_type":"4"}},{"id":1854138,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T22:30:09.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":158263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 13, 2024 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":158263,"derivative":{"exercise_price":2.99,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":158263},"source":{"system":"sec-edgar","filing":"0001326110-23-000090","document":"wk-form4_1686868200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000090/wk-form4_1686868200.xml","form_type":"4"}},{"id":2231334,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T01:26:37.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":167937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 14, 2023 or the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":167937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":167937},"source":{"system":"sec-edgar","filing":"0001326110-22-000052","document":"wf-form4_165534277881126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000052/wf-form4_165534277881126.xml","form_type":"4"}},{"id":2669971,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T22:36:32.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":26064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2022 or the date immediately preceding the 2022 annual meeting of stockholders."}],"balance_after":26064,"derivative":{"exercise_price":14.91,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":26064},"source":{"system":"sec-edgar","filing":"0001209191-21-040354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121040354/doc4.xml","form_type":"4"}},{"id":2726958,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32090,"kind":"person","name":"Selecky Christobel","position":1,"cik":"0001849739","reported_name":"Selecky Christobel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-05T22:06:54.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":21873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, the shares subject to the award will vest in three (3) equal installments on each of March 9, 2022, March 9, 2023 and March 9, 2024, such that the award will be fully vested March 9, 2024."}],"balance_after":21873,"derivative":{"exercise_price":17.24,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":21873},"source":{"system":"sec-edgar","filing":"0001209191-21-030448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121030448/doc4.xml","form_type":"4"}}]}